Premium
Metropolis Healthcare Ltd, India’s second-largest pathology chain after Dr Lal PathLabs, has made back-to-back acquisitions in the past four months to expand its footprint in northern India. In December 2024, it acquired oncology-focused diagnostic services provider Core Diagnostics for $29 million (Rs 246.8 crore at that time). This was followed ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.